0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Announcement |

New Appointments to the Editorial Board FREE

JAMA Neurol. 2013;70(1):18. doi:10.1001/jamaneurol.2013.693.
Text Size: A A A
Published online

With this issue of JAMA Neurology, we welcome Merit E. Cudkowicz, MD, MSc, Randolph S. Marshall, MD, MS, and Benjamin M. Greenberg, MD, to our Editorial Board. We know they will provide the necessary knowledge and scholarship to allow JAMA Neurology to continue to develop and excel. At the same time, we wish to express our profound thanks to James I. Ausman, MD, PhD, Audrey S. Penn, MD, and E. Steve Roach, MD, for serving on the board.

Drs Ausman, Penn, and Roach have served on the Editorial Board since 1997 and their contributions to the development of the journal have been truly significant. We are most grateful to them for their continued efforts on our behalf for the past 15 years. Dr Roach has been selected as the new editor of Pediatric Neurology and we congratulate him and the journal. He will bring outstanding scholarship to this editorship and we wish him great success.

Dr Cudkowicz is the Julieanne Dorn Professor of Neurology at Harvard Medical School and chief of the Neurology Service at the Massachusetts General Hospital, Boston. She received the Sheila Essey ALS Award of the American Academy of Neurology in 2009. She is currently a funded principal investigator of the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke for a “Clinical Trial of Ceftriaxone in Patients With ALS” and for a study on “Coenzyme Q10 in Huntington's Disease.” Dr Cudkowicz's research and clinical activities are dedicated to the study and treatment of patients with neurodegenerative disorders. Her research focus has been on developing novel treatments for amyotrophic lateral sclerosis and Huntington disease. Dr Cudkowicz brings to our Editorial Board a vast experience in clinical and basic neurological research, a distinguished record of scientific publications, and national and international lectureships. Dr Cudkowicz will provide JAMA Neurology with an impressive record and experience in neuromuscular and neurodegenerative diseases that will be invaluable in considering papers for publication and establishing our future editorial plans. We welcome Dr Cudkowicz warmly as a member of the JAMA Neurology Editorial Board.

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Merit E. Cudkowicz, MD, MSc

Dr Marshall is professor of neurology at the Neurological Institute of Columbia University Medical Center in New York, where he is chief of the Stroke Division. He is a funded investigator of the NIH/National Institute of Neurological Disorders and Stroke studying “Blood Flow and Cognition.” He has published more than 70 original peer reviewed research articles in addition to invited chapters and reviews. He has been invited to give the C. Miller Fisher Lecture at the Massachusetts General Hospital in 2013. Dr Marshall brings great scholarship and publishing experience to the field of cerebrovascular disease and stroke syndromes and his joining our Editorial Board will provide us with additional significant depth and knowledge. Dr Marshall is a distinguished clinician, teacher, and investigator and we welcome him enthusiastically as a new member of the JAMA Neurology Editorial Board.

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Randolph S. Marshall, MD, MS

Dr Greenberg, director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program and a Cain Denius Scholar in Mobility Disorders in the departments of neurology and neurotherapeutics and pediatrics at the University of Texas Southwestern Medical Center at Dallas, will become a member of our Editorial Board and section editor of Viewpoints beginning with this issue, the initial publication of JAMA Neurology. Dr Greenberg received his neurology training at the Johns Hopkins Hospital and postdoctoral fellowship training at the Johns Hopkins School of Public Health. He is coinvestigator on 2 NIH grants funded to study genetic and environmental risk factors for pediatric multiple sclerosis and neuromyelitis optica. He has published more than 30 articles emphasizing the clinical features, immunology, and clinical trials for new therapies for demyelinating diseases.

Viewpoints is a new initiative for JAMA Neurology and will provide our readers with perspectives on emerging issues in clinical practice, neuroeconomics, neuroethics, neuropolitics, neuroethology, NIH research grant funding opportunities and perspectives, clinical trial results, neurology residency and fellowship news and attitudes, and other cutting edge controversies and issues of importance to the greater neurological community. Dr Greenberg has a real interest and expressed insights into all of these matters and Viewpoints under his guidance will become, we believe, a lively and stimulating forum. Stay tuned!

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Benjamin M. Greenberg, MD

Figures

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Merit E. Cudkowicz, MD, MSc

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Randolph S. Marshall, MD, MS

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Benjamin M. Greenberg, MD

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

670 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs